Editorial: Heterogeneity in breast cancer: clinical and therapeutic implications

被引：2
|
作者：
Carlino, Francesca [1 ]
Solinas, Cinzia [2 ]
Orditura, Michele [3 ]
Bisceglia, Maria Dezia [4 ]
Pellegrino, Benedetta [5 ]
Diana, Anna [6 ]
机构：
[1] Osped Ave Gratia Plena, Med Oncol Unit, San Felice A Cancello, Caserta, Italy
[2] Azienda Osped Univ AOU Cagliari Policlin Duilio Ca, Azienda Osped Univ AOU Cagliari Policlin Duilio Ca, Cagliari, Italy
[3] Med Oncol Unit, Aienda Osped Rilievo Nazl AORN St Anna & San Sebas, Caserta, Italy
[4] Aienda Osped Rilievo Nazl AORN St Anna & San Sebas, Aienda Ospedaliera Rilievo Nazl A O R N St Anna &, Caserta, Italy
[5] Univ Hosp Parma, Med Oncol & Breast Unit, Parma, Italy
[6] Osped Mare, Med Oncol Unit, Naples, Italy
来源：
FRONTIERS IN ONCOLOGY | 2024年 / 14卷
关键词：
breast cancer; heterogeneity; molecular mechanisms; drug resistance; emerging technologies;
D O I：
10.3389/fonc.2024.1321654
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [21] Clinical Utility and Therapeutic Implications of Oncotype Analysis in Patients With Breast Cancer
    Tatarian, Talar
    Damle, Sameer
    McSwain, Anita P.
    Ojong-Ntui, Martin
    Tabbara, Imad
    Teal, Christine B.
    ANNALS OF SURGICAL ONCOLOGY, 2011, 18 : S182 - S182
  • [22] Clinical utility and therapeutic implications of oncotype analysis in patients with breast cancer
    Williams, Stephanie A.
    Tatarian, Talar
    Teal, Christine B.
    McSwain, Anita P.
    Siegel, Robert S.
    Ojong-Ntui, Martin
    Saini, Ashima
    Tabbara, Imad A.
    Kaltman, Rebecca Davidson
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [23] CLINICAL-TRIALS AND PRIMARY BREAST-CANCER - THE THERAPEUTIC IMPLICATIONS
    CARTER, K
    CANCER, 1984, 53 (03) : 740 - 751
  • [24] Clinical management of breast cancer heterogeneity
    Zardavas, Dimitrios
    Irrthum, Alexandre
    Swanton, Charles
    Piccart, Martine
    NATURE REVIEWS CLINICAL ONCOLOGY, 2015, 12 (07) : 381 - 394
  • [25] Clinical management of breast cancer heterogeneity
    Dimitrios Zardavas
    Alexandre Irrthum
    Charles Swanton
    Martine Piccart
    Nature Reviews Clinical Oncology, 2015, 12 : 381 - 394
  • [26] Heterogeneity of breast cancer and implications of adjuvant chemotherapy
    A. Rab Razzak
    Nancy U. Lin
    Eric P. Winer
    Breast Cancer, 2008, 15 : 31 - 34
  • [27] Heterogeneity of breast cancer and implications of adjuvant chemotherapy
    Razzak, A. Rab
    Lin, Nancy U.
    Winer, Eric P.
    BREAST CANCER, 2008, 15 (01) : 31 - 34
  • [28] Breast cancer heterogeneity: mechanisms, proofs, and implications
    Hsiao, Yi-Hsuan
    Chou, Ming-Chih
    Fowler, Carol
    Mason, Jeffrey T.
    Man, Yan-Gao
    JOURNAL OF CANCER, 2010, 1 : 6 - 13
  • [29] Genomics in breast cancer - therapeutic implications
    Lonning, PE
    Sorlie, T
    Borresen-Dale, AL
    NATURE CLINICAL PRACTICE ONCOLOGY, 2005, 2 (01): : 26 - 33
  • [30] Genomics in breast cancer—therapeutic implications
    Per Eystein Lønning
    Therese Sørlie
    Anne-Lise Børresen-Dale
    Nature Clinical Practice Oncology, 2005, 2 : 26 - 33
12345